Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.

Baird Downgrades Graco to Neutral, Announces $61 Price Target

Baird analyst Michael Halloran downgrades Graco (NYSE:GGG) from Outperform to Neutral and announces $61 price target.
byBenzinga Newsdesk
July 14, 2022
1 minute read
Total
0
Shares
0
0
0
0
0
0

Baird analyst Michael Halloran downgrades Graco (NYSE:GGG) from Outperform to Neutral and announces $61 price target.

 
Total
0
Shares
Share 0
Tweet 0
Share 0
Share 0
Share 0
Share 0
Related Posts
Read More

Orthopedic Devices Maker Treace Medical Concepts’ Gloomy Forecast Cast Concerns Over Long-Term Viability

By Vandana Singh
May 8, 3:08 PM
Treace Medical Concepts reports Q1 EPS loss of $(0.30), sales hit $51.11 million, up 21%. Surge in procedure kits sold due to expanded surgeon base and product mix shift. FY24 sales guidance adjusted to $201M-$211M. Analysts downgrade, citing competitive challenges.

TMCI